Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia
The current goal of diabetes therapy is to reduce time-averaged mean levels of glycemia, measured as HbA1c, to prevent diabetic complications. However, HbA1c only explains
Gespeichert in:
Veröffentlicht in: | The Journal of experimental medicine 2008-09, Vol.205 (10), p.2409-2417 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The current goal of diabetes therapy is to reduce time-averaged mean levels of glycemia, measured as HbA1c, to prevent diabetic complications. However, HbA1c only explains |
---|---|
ISSN: | 0022-1007 1540-9538 |
DOI: | 10.1084/jem.20081188 |